LA

Lovisa Afzelius

General Partner at Flagship Pioneering

Belmont, Massachusetts

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $15,000,000.00
  • Target Investment:

    $7,000,000.00

Work Experience

  • General Partner

    2023

    Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $25 billion in aggregate value

  • Origination Partner

    2020 - 2024

2020

  • Founding CEO & Director

    2020

  • Co-founder & CEO

    2020

  • Co-founder & CEO

    2021

  • Co-founder & CEO

    2022

  • Board Member | Co-founder

    2022

  • Chairman Of The Board | Co-Founder

    2017 - 2022

  • President

    2020 - 2021

  • Senior Vice President

    2017 - 2020

    Corporate Strategy and Operations Computational Sciences | Legal | Finance | Corporate Strategy | Search & Evaluation | R&D Operations A Flagship Pioneering Company

2013 - 2017

  • Executive Director, Head of Systems Immunology

    2017 - 2017

    Leading the computational systems immunology, molecular profiling, cytometry profiling and external alliances groups towards an understanding of immune dysfunction and therapeutic mechanisms in human disease. Clinical Research Project Leader, Phase I/II, Immunology

  • Head of Computational Precision Medicine, Senior Director, Inflammation & Immunology RU

    2015 - 2017

    Predictive modeling for patient stratification, disease baseline and target validation Clinical Research Project Leader - Autoimmune diseases

  • Senior Director , Immunoscience RU

    2013 - 2015

    Clinical Research Project Leader - Autoimmune diseases